NHS Innovation Accelerator Fellowship 2027: Three Years of NHS Scale-Up Support, Applications Close 27 September 2026

NHS Innovation Accelerator Fellowship 2027: Three Years of NHS Scale-Up Support, Applications Close 27 September 2026

The NHS Innovation Accelerator (NIA) is opening its 2027 intake to people who are already leading a health or care innovation with evidence of real-world impact. This is a selective fellowship and scale-up programme, not an idea-stage incubator or a conventional research grant. The strongest applicants will have a solution that is in use, a credible route to wider adoption, and enough organisational support to spend substantial time on implementation and partnership work.

Applications open on 17 August 2026. Applicants must start the Readiness Check by 12:00 noon on Friday 25 September 2026, then complete the invited Main Application by 23:59 on Sunday 27 September 2026. The programme plans to recruit up to 24 new Fellows for 2027. Fellows receive a structured programme lasting up to three years, with tailored advice, expert mentors, access to NHS and Health Innovation Network connections, peer learning, showcase opportunities, and practical help with adoption. The official materials do not state a standard cash stipend or prize amount, so applicants should treat the opportunity as a supported fellowship rather than assume it provides salary replacement or unrestricted grant money.

Key details

What the Fellowship offers

The NIA exists to help proven innovations move through the difficult part between successful testing and broad adoption. A product can work in one hospital and still face major barriers when another NHS organisation considers buying, deploying, integrating or commissioning it. The programme focuses its support on those barriers: building a persuasive business case, identifying decision-makers, understanding procurement, developing partnerships, improving communication, and adapting the implementation plan to different settings.

The 2027 call describes a structured three-year programme. Year 1 includes quarterly events and learning sessions on subjects such as procurement, communications, behavioural science, and legal or intellectual-property issues. Fellows can also receive introductions, specialist advice and signposting to relevant expertise. The programme connects Fellows with all 15 Health Innovation Networks, as well as national bodies, professional networks, innovators and NHS leaders. The exact support package is tailored to each Fellow’s innovation, objectives and stage of development.

There is also a visibility and peer-learning component. Fellows may present at regional or national events and contribute insights to policy and strategy discussions. A growing community of Fellows and alumni provides a place to compare adoption problems and share practical lessons. These benefits are valuable for an organisation that needs NHS relationships and implementation knowledge, but they are not a promise of procurement, sales, investment or a particular number of NHS deployments.

The opportunity is delivered by UCLPartners in partnership with NHS England and the Health Innovation Networks. The call says the programme is funded by NHS England and that all 15 networks provide direct financial support and governance to the programme. That description concerns operation of the NIA; it does not confirm that every Fellow receives a separate cash payment. Budget for staff time, travel, regulatory work and implementation should therefore be planned independently.

Who should apply

The NIA awards the Fellowship to one individual who represents the innovation. That person may be the inventor, the lead for the innovation within an organisation, or another representative with enough influence to shape its adoption and spread strategy. Teams and partner organisations can support the work, but the application must name a single applicant and the applicant section must be written in the first person.

The programme welcomes applicants from public bodies, universities and research institutions, charities, social enterprises, community organisations, small and medium-sized enterprises, and large companies. Clinicians, administrators, social workers, entrepreneurs and other healthcare professionals can fit the programme when they have a meaningful role in taking the innovation forward. International companies may apply, and the FAQ says the company itself does not have to be UK-based. However, the applicant should be mainly based in the UK because several activities are in person, and an international innovation should ideally already have some UK presence.

The person applying needs more than a good product story. The call asks for communication and collaboration, a learning mindset, an external orientation, an entrepreneurial approach, and strong values. The applicant should be able to work with patients, carers, communities, clinicians, commissioners and system leaders. The organisation must support the person’s Fellowship place and the approximately two-day-per-week commitment. If the person cannot obtain that support, the opportunity is likely to be a poor fit even if the innovation itself is strong.

What counts as a suitable innovation

The NIA is aimed at the transition-to-scale stage. It is not intended for a concept, an early prototype, or a project whose main purpose is to generate initial research findings. The innovation should have been tested through pilots, clinical trials or other real-world settings and should have a robust evidence base showing measurable improvement in outcomes or a meaningful direct or indirect health impact.

The call normally expects the innovation to have been deployed in an NHS or care setting in the UK or internationally. It should be ready for further adoption across the NHS, have a financially sustainable model, and have a realistic pathway to scale. Applicants also need to consider intellectual property, regulation, ethics and information governance. Digital innovations should be interoperable with core NHS systems. The NIA specifically excludes early-stage or primarily research-focused work, drug-dose or clinical-administration testing, research into the causes or treatment of illness, and interventions that are primarily education or training.

The 2027 focus areas include access, productivity, Modern Service Framework priorities and women’s health. Examples include digital triage, remote consultations, urgent-care routing, NHS App and data-platform integration, community diagnostics, predictive prevention, ambient documentation, discharge management, workforce planning, medicines optimisation, virtual wards, mental health, cardiovascular disease, sepsis, dementia, children’s health, menopause support, maternity safety and clinical-trial participation. These are priority signals rather than a substitute for evidence. An innovation outside the examples may still be relevant if it addresses a current NHS need and demonstrates a convincing case for adoption.

Evidence and eligibility checklist

Before applying, map the innovation against the call’s checklist. You should be able to show the problem it addresses, why current practice is insufficient, and how the solution improves care or system performance. Evidence should go beyond testimonials. Useful material may include before-and-after outcomes, controlled or comparative results where available, implementation data, patient-reported outcomes, waiting-time or capacity measures, cost or health-economic analysis, adoption records, and documented feedback from users and purchasers.

Patient and public involvement is central to the call. Explain how patients, carers or communities shaped the innovation and how they will continue to influence its development and rollout. Address health inequalities directly: identify which groups could benefit, which groups could be excluded or harmed, and what design or implementation choices reduce that risk. If the solution is digital, explain accessibility, data exchange and deployment requirements rather than relying on a general claim that it is scalable.

The application should also make the applicant’s role clear. Show the decisions you have made, the partnerships you have built, and the barriers you have already handled. Identify colleagues and partners who bring complementary expertise in stakeholder engagement, business cases, adoption strategy, change management, commercial work, regulation or implementation. The Fellowship is awarded to an individual, but the NIA expects that person to work through a wider team.

How the application works

The first step is the online Readiness Check. It is designed to test basic fit before an applicant spends time on the full form. The NIA says it aims to review the check and respond within three working days, so submitting early is sensible. The check must be started by noon on 25 September 2026. Applicants who meet the criteria will be invited by email to complete the Main Application.

The Main Application must be completed by 23:59 on 27 September 2026. The call identifies four main components: the application form, authorisation from the employing organisation, two references, and additional supporting information where relevant. Late applications will not be accepted. Read the 2027 Call for Applications, Key Dates document and FAQs before starting, and review the draft Fellowship contract and Code of Conduct because the successful applicant and organisation will need to sign the final documents.

After submission, the NIA team screens applications for completeness, a single named lead, sufficient innovation maturity, the two-day commitment, evidence of impact, and use in at least one health or social care site. A group of at least five assessors drawn from patient, clinical, commercial and implementation backgrounds scores the applicant and innovation sections. Applications need at least 65% in each section to be offered an interview. NICE and NHS England may informally review shortlisted applications, particularly for guideline alignment, evidence concerns and fit with NHS direction.

Successful interviewees receive a conditional place subject to due diligence. References are checked, intellectual-property arrangements are confirmed, information-governance checklists are completed, and attendance at compulsory dates is verified. A final unconditional offer and signed contracts follow successful due diligence. Unsuccessful applicants at assessment and interview stages are due to receive written feedback.

Timeline and time commitment

Applications are open from 17 August to 27 September 2026. Assessment is scheduled for 5 October to 6 November, with a shortlisting panel on 24 November and applicant notifications on 25 November. Interviews take place from 6 to 15 January 2027. The final decision panel is scheduled for 4 February, with outcomes communicated on 5 February and feedback sent by 26 February.

Due diligence and onboarding run from 8 February to 5 March 2027, with onboarding documents due by 19 February. The mandatory programme calendar then begins with induction on 9 March, a launch dinner on 15 March (marked provisional in the call), a launch event on 16 or 17 March, and a panel day on 20 April. Year 1 quarterly events are scheduled for May, July and October 2027, followed by a March 2028 quarterly event. Learning events are scheduled for June and September 2027 and February 2028.

Fellows are expected to commit about two days per week to scaling the innovation and participating in NIA activity. Some people may use time already included in their role; clinicians may need to arrange protected time alongside existing duties. Mandatory sessions must be attended. Fellows also participate in the learning programme, share experience with peers, report progress quarterly, contribute to evaluation, and demonstrate continuing engagement. Progression from Year 1 into Years 2 and 3 depends on meeting programme requirements and making reasonable progress.

How to prepare a competitive application

Start with a one-page evidence map. State the unmet need, the affected population, the intervention, the setting where it has been used, the measurable result, and the next adoption decision you need to make. Then attach a source to every material claim. If the evidence is observational, say so. If a result comes from one site or a small cohort, define the boundary instead of presenting it as NHS-wide proof.

Next, build an adoption plan for a real NHS buyer or partner. Name the decision-makers, procurement route, implementation dependencies, workforce implications, integration work and likely objections. Include the financial case where possible: costs avoided, capacity released, staff time saved, patient benefit, or the cost of maintaining current practice. A strong plan connects the evidence to a specific scaling decision rather than describing growth in abstract terms.

Use the patient and equity sections to show work already done. Describe who was involved, what changed because of their input, and how you will monitor different outcomes across groups. Check that regulatory, ethical, data-protection and intellectual-property arrangements are current. Finally, ask your employer for written authorisation early, confirm the two references, and reserve every compulsory date in the published calendar.

Common mistakes to avoid

Do not apply with an idea that has not been deployed. The NIA is looking for innovations already used in health or care and ready for wider adoption. Do not substitute market interest, a prototype demonstration or a research plan for real-world evidence.

Do not make the application about the organisation alone. The Fellowship is awarded to an individual, so explain what you personally lead, how you make decisions, and how you learn from partners. At the same time, do not pretend you can scale alone: identify the team, NHS partners and specialist capabilities that make delivery credible.

Do not treat a priority area as automatic eligibility. A product that mentions AI, interoperability or women’s health still needs evidence, patient benefit and a workable NHS route. Do not promise procurement or national adoption because the NIA offers connections; the programme supports the path but does not guarantee a contract.

Finally, do not leave the Readiness Check or employer authorisation until the last day. The two-stage route has separate deadlines, and the Main Application is available only after an invitation. The 2027 documents also say that late applications will not be accepted.

Frequently asked questions

Is this a cash scholarship or grant?

No standard Fellow stipend or cash award is stated in the 2027 call. It is best understood as a funded, three-year support programme for innovators, with mentoring, networks, learning, visibility and tailored scale-up assistance. Confirm any employment, travel or project-cost arrangements directly with the NIA before relying on them.

Must the company be based in the UK?

No. The FAQ says overseas applicants and companies can apply. The applicant should be mainly based in the UK because key events are in person, and the innovation should ideally have some UK presence. An international company that is only beginning to enter the NHS may need to build local relationships first.

Can a clinician or charity apply?

Yes. The call welcomes public-sector applicants, clinicians, universities, charities, social enterprises, community organisations, SMEs and large corporates. The deciding issue is whether the person represents a validated innovation and can influence its adoption and scale.

How many people from one team can be Fellows?

Each application names one Fellow. The applicant can describe the roles of colleagues and partners, and some events may include the wider team, but the Fellowship commitment belongs to the named individual.

What should I do if the innovation is not ready?

Use the readiness criteria honestly. If the innovation is still primarily research, lacks real-world deployment or has no evidence of impact, this intake is probably premature. The official call says that applicants found ineligible at the Readiness Check will receive signposting and guidance about possible next steps and other support.

Official links and next steps

Read the official NHS Innovation Accelerator application page for the online application route and current resource library. Before applying, read the official 2027 Call for Applications, Key Dates document, and 2027 FAQs. Questions about eligibility or readiness can be sent to [email protected].

The practical first move is to check three things before 17 August: whether your innovation has evidence from a real health or care setting, whether you can show a credible route to NHS adoption, and whether your employer will protect approximately two days each week for the programme. If those conditions are in place, prepare the evidence map, employer authorisation and references before the application window opens. Start the Readiness Check well before noon on 25 September, then reserve time to complete the Main Application by 23:59 on 27 September 2026.